Discover the full record of transactions filed by 손인동, Director. Insider active across 2 companies, notably 비보존 제약. In total, 93 filings have been logged. History available since 5 March 2026. The latest transaction was disclosed on 30 April 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Declarations 93 total
● Executives · 26 May 2026 (filed) · 비보존 제약 277,778 shares DART:20260526000366 ● - · Executives · 30 Apr 2026 · 비보존 제약 277,778 shares @ ₩9,000.00 0.0007% mcap 100.0% of flow Share DART:20260507000560 Ideal exit: 25 Jan 2027 (T+270) ● 상무 · Executives · 15 Apr 2026 (filed) · 비보존 제약 Share DART:20260415000508 Ideal exit: 10 Jan 2027 (T+270) ● 사내이사 · Executives · 15 Apr 2026 (filed) · 비보존 제약 Share DART:20260415000525 Ideal exit: 10 Jan 2027 (T+270) ● Executives · 9 Apr 2026 (filed) · 비보존 제약 180,954 shares DART:20260409002937 ● 사내이사 · Executives · 6 Apr 2026 (filed) · 비보존 제약 Share DART:20260406003902 Ideal exit: 1 Jan 2027 (T+270) ● - · Executives · 31 Mar 2026 · 비보존 제약 180,954 shares @ ₩9,000.00 0.0005% mcap 100.0% of flow Share DART:20260403003027 Ideal exit: 26 Dec 2026 (T+270) ● Executives · 31 Mar 2026 (filed) · 비보존 제약 ● Executives · 23 Mar 2026 (filed) · 비보존 제약 ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 938 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000131 Ideal exit: 30 Nov 2026 (T+270) ● - · Executives · 5 Mar 2026 · 비보존 제약 1,067,850 shares @ ₩3,065.00 0.0005% mcap 100.0% of flow Share DART:20260312000892 Ideal exit: 30 Nov 2026 (T+270) ● Executives · 12 Mar 2026 (filed) · 비보존 제약 2,218 shares DART:20260312001007 Ideal exit: 7 Dec 2026 (T+270) ● 이사 · Executives · 5 Mar 2026 · 비보존 제약 6,694 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000416 Ideal exit: 30 Nov 2026 (T+270) ● 사내이사 · Executives · 5 Mar 2026 · 비보존 제약 30,232 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000316 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 3,531 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312001284 Ideal exit: 30 Nov 2026 (T+270) ● 이사 · Executives · 5 Mar 2026 · 비보존 제약 452 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260312000032 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 4,540 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260311003296 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 5 Mar 2026 · 비보존 제약 1,419 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260311003307 Ideal exit: 30 Nov 2026 (T+270) ● 대표이사 · Executives · 5 Mar 2026 · 비보존 제약 19,897 shares @ ₩3,065.00 0.0000% mcap 100.0% of flow Share DART:20260311003174 Ideal exit: 30 Nov 2026 (T+270) ● 상무 · Executives · 12 Feb 2026 (filed) · 비보존 제약 Share DART:20260212000183 Ideal exit: 9 Nov 2026 (T+270) ● Executives · 6 Feb 2026 (filed) · 비보존 제약 3,216,188 shares DART:20260206001696 ● - · Executives · 6 Feb 2026 (filed) · 비보존 제약 Share DART:20260206000730 ● - · Executives · 6 Feb 2026 (filed) · 비보존 제약 Share DART:20260206001570 ● 대표이사 · Executives · 2 Feb 2026 (filed) · 비보존 제약 Share DART:20260202000458 Ideal exit: 30 Oct 2026 (T+270) ● 상무 · Executives · 30 Jan 2026 (filed) · 비보존 제약 Share DART:20260130000418 Ideal exit: 27 Oct 2026 (T+270) 25 of 93 declarations
Load more (68 remaining) About 손인동 Son In-dong is a Board Member at 비보존 제약, a pharmaceutical company. As a Board Member, he participates in strategic decision-making and oversees the company's projects. His role is essential for the development of new medical solutions.